Please wait while we open this resource.
K
Clinical reviews
SAFETY, TOLERABILITY, AND EFFICACY OF UP-TITRATION OF GUIDELINE-DIRECTED MEDICAL THERAPIES FOR ACUTE HEART FAILURE (STRONG-HF): A MULTINATIONAL, OPEN-LABEL, RANDOMISED, TRIAL
Université Paris Cité, INSERM UMR-S 942 (MASCOT), Paris, France
PDF202215 pages1.6 MB
The STRONG-HF trial aimed to evaluate the impact of high-intensity care on the up-titration of heart failure medications compared to usual care. It involved a diverse cohort of patients and measured various outcomes related to heart failure management. The study's results indicate significant differences in medication dosing and patient follow-up between the two care groups, highlighting the importance of structured outpatient visits in optimizing treatment.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology